Revenue from pharma tests, enterprise sales, and other customers in the range of $15 to $16 million; Revenue from population sequencing is expected to be zero due to completion of the prior VA MVP task order
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.